Lubrizol Invests Millions to Expand Particle Sciences

The Lubrizol Corporation, which acquired Ben Franklin client Particle Sciences, will invest millions to add commercial drug product manufacturing at the company’s facility in Bethlehem. Leveraging the company’s knowledge in complex formulations and production, the new space is expected to be operational in the fourth quarter of 2017. More: http://prn.to/2sgCKE1